| 通報號: G/TBT/N/USA/1199 |
ICS號: 11.040
|
發(fā)布日期: 2016-09-28
|
截至日期: 2016-09-28
|
通報成員: 美國
|
目標(biāo)和理由: 保護人類安全和健康
|
內(nèi)容概述: 食品藥品管理局(FDA)現(xiàn)將斜視檢測設(shè)備分到II類(特別管控)。適用于該類設(shè)備的特別管控在本法令中確定,將成為斜視檢測設(shè)備分類編纂語言的一部分。FDA現(xiàn)將此類設(shè)備歸為II類(特別管控),以便為此類設(shè)備的安全和功效提供合理的保證。
|
正文:
| 世界貿(mào)易組織 |
G/TBT/N/USA/1199
2016-09-28
16-5180
|
| |
| 技術(shù)性貿(mào)易壁壘 |
原文:英語
|
通 報
以下通報根據(jù)TBT協(xié)定第10.6條分發(fā)
| 1. |
通報成員: 美國
如可能,列出涉及的地方政府名稱 ( 3.2條和7.2 條):
|
| 2. |
負責(zé)機構(gòu):衛(wèi)生及公共服務(wù)部(HHS)食品藥品管理局(FDA) [1219]
|
| 3. |
通報依據(jù)條款:
[ ] 2.9.2
[ ] 2.10.1
[ ] 5.6.2
[ ] 5.7.1
通報依據(jù)的條款其他: X
|
| 4. |
覆蓋的產(chǎn)品: 斜視檢測設(shè)備。醫(yī)療設(shè)備。 ICS: 11.040 HS:
HS編碼:90185000 ICS編碼:11.040
|
| 5. |
通報標(biāo)題: 醫(yī)療設(shè)備;眼科設(shè)備;斜視檢測設(shè)備分類。
語言:英語 頁數(shù):3 鏈接網(wǎng)址:
|
| 6. |
內(nèi)容簡述: 食品藥品管理局(FDA)現(xiàn)將斜視檢測設(shè)備分到II類(特別管控)。適用于該類設(shè)備的特別管控在本法令中確定,將成為斜視檢測設(shè)備分類編纂語言的一部分。FDA現(xiàn)將此類設(shè)備歸為II類(特別管控),以便為此類設(shè)備的安全和功效提供合理的保證。
|
| 7. |
目標(biāo)與理由:保護人類健康安全。
|
| 8. |
相關(guān)文件: 2016年9月22日聯(lián)邦紀(jì)事(FR)第81卷第65279頁;聯(lián)邦法規(guī)法典(CFR)第21編第886部分。
|
| 9. |
擬批準(zhǔn)日期:2016/06/08
擬生效日期:2016/09/22
|
| 10. |
意見反饋截止日期: -
|
| 11. |
文本可從以下機構(gòu)得到:
[ ] 國家通報機構(gòu)
[ ] 國家咨詢點,或其他機構(gòu)的聯(lián)系地址、傳真及電子郵件地址(如能提供):
|
|
正文(英):
NOTIFICATION
The following notification is being circulated in accordance with Article 10.6
|
1.
|
Notifying Member: United States of America
If applicable, name of local government involved (Article 3.2 and 7.2):
|
|
2.
|
Agency responsible: Food and Drug Administration (FDA), Health and Human Services (HHS) [1219]
Name and address (including telephone and fax numbers, email and website addresses, if available) of agency or authority designated to handle comments regarding the notification shall be indicated if different from above:
Please submit comments to: USA WTO TBT Enquiry Point
Email: usatbtep@nist.gov
|
|
3.
|
Notified under Article 2.9.2 [ ], 2.10.1 [ ], 5.6.2 [ ], 5.7.1 [ ], other: X
|
|
4.
|
Products covered (HS or CCCN where applicable, otherwise national tariff heading. ICS numbers may be provided in addition, where applicable): Strabismus detection device. Medical equipment (ICS: 11.040)
|
|
5.
|
Title, number of pages and language(s) of the notified document: Medical Devices; Ophthalmic Devices; Classification of Strabismus Detection Device (3 pages, in English)
|
|
6.
|
Description of content: The Food and Drug Administration (FDA) is classifying the strabismus detection device into class II (special controls). The special controls that will apply to the device are identified in this order and will be part of the codified language for the strabismus detection device's classification. The Agency is classifying the device into class II (special controls) in order to provide a reasonable assurance of safety and effectiveness of the device.
|
|
7.
|
Objective and rationale, including the nature of urgent problems where applicable: Protection of human health or safety
|
|
8.
|
Relevant documents: 81 Federal Register (FR) 65279, 22 September 2016; Title 21 Code of Federal Regulations (CFR) Part 886
|
|
9.
|
Proposed date of adoption: 8 June 2016
Proposed date of entry into force: 22 September 2016
|
|
10.
|
Final date for comments: –
|
|
11.
|
Texts available from: National enquiry point [ ] or address, telephone and fax numbers and email and website addresses, if available, of other body:
https://members.wto.org/crnattachments/2016/TBT/USA/16_4030_00_e.pdf
|
|
| |
|
| |
|
|
|
本網(wǎng)維權(quán)及免責(zé)聲明:
①凡本網(wǎng)所有原始/編譯文章及圖片、圖表的版權(quán)均屬江蘇省技術(shù)性貿(mào)易措施信息平臺(www.tbtguide.com)所有,如要轉(zhuǎn)載,需注明"信息來源:江蘇省技術(shù)性貿(mào)易措施信息平臺"或"信息來源:tbtguide"。違反上述規(guī)定者,本網(wǎng)將保留追究其侵權(quán)責(zé)任的權(quán)利。
②凡本網(wǎng)注明"信息來源:XXX(非tbtguide)"的作品,均轉(zhuǎn)載自其他媒體,轉(zhuǎn)載目的在于傳遞更多的信息,并不代表本網(wǎng)贊同其觀點和對其真實性負責(zé)。
聯(lián)系E-mail:js_wto@163.com |